Table 3.

Sub-group analysis of the ophthalmic manifestations of the mpox patients.

Factors	Estimate (95% CI)	p	I2	P Subgroup
Endemicity				<0.001
Non-endemic	1.05 [0.09–2.68]	0.07	53.93%
Endemic	27.22 [13.69–43.26]	<0.001	98.09%
Waves of outbreak				<0.001
2022 multi-country outbreak	0.61 [0.13–1.31]	0.55	0%
Pre-2022 outbreak	24.78 [12.41–39.62]	<0.001	97.84%
Continent				<0.001
Europe	0.98 [0.14–2.31]	-	-
Africa	27.22 [12.69–43.26]	<0.001	98.09
North America	8.82 [3.05–22.96]	-	-
Multi-continent	0.57 [0.19–1.66]	-	-